Dr Sudha Garg
Director of Radiopharmaceutical Sciences
Sudha Garg, Ph.D., is the Director of Radiopharmaceutical Sciences for the Center for Molecular Imaging and Therapy (CMIT). Her research focuses on the development of novel radiopharmaceuticals for diagnostic and therapeutic applications. Her strengths include developing novel strategies to synthesize radiopharmaceuticals, developing and optimizing radiolabeling methods for difficult to prepare radiopharmaceuticals, and establishing the routine manufacturing of radiopharmaceuticals for pre-clinical research and for their use in clinical research.
Some of her key contributions to CMIT include implementation of regulatory compliance at Shreveport and Baton Rouge Southern Isotopes sites, establishing the routine production of F-DOPA, AV-1451, and F-18 FLT at the Southern Isotope Shreveport facility, and streamlining the cGMP manufacturing aspects at Shreveport and Baton Rouge facilities.
Dr. Garg earned a Bachelor of Science from Osmania University and a Master of Science in organic chemistry from Lucknow University. She received a Ph.D. in medicinal chemistry from Lucknow University. In continuation of her academic career, Dr. Garg served as a postdoctoral fellow in the Department of Chemistry at North Carolina State University. Following, she served as a research associate at the Department of Radiology at Duke University Medical Center and as a research fellow in the Department of Psychiatry at Yale University.
Prior to joining BRF in 2013, Dr. Garg was an associate professor of radiologic sciences at the Wake Forest School of Medicine where she was also the director of the PET/SPECT Radiopharmaceutical Section of the ligand laboratories. Prior to joining Wake Forest, Dr. Garg was the chief radiochemist and director of the radiochemistry laboratories at Molecular NeuroImaging, LLC.